Global Transdermal Drug Delivery Formulation Market Research Report 2025

Publication ID:

PB505255241

Publication Date:

May 29, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Transdermal Drug Delivery Formulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Transdermal Drug Delivery Formulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transdermal Drug Delivery Formulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transdermal Drug Delivery Formulation in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transdermal Drug Delivery Formulation include Johnson & Johnson, Mylan, Echo Therapeutics, Novartis, GSK, Hunan Jiudian, Tide Pharmaceutical, Luye Pharma, GDB, Anssure Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Formulation.
The Transdermal Drug Delivery Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Mylan
Echo Therapeutics
Novartis
GSK
Hunan Jiudian
Tide Pharmaceutical
Luye Pharma
GDB
Anssure Pharma
Novastage
LIANSN
KBD
CosMED Pharmaceutical
Segment by Type
Ointment
Glue
Cataplasm
Other
Segment by Application
Hospital
Drug Store
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ointment
1.2.3 Glue
1.2.4 Cataplasm
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Formulation Market Perspective (2020-2031)
2.2 Global Transdermal Drug Delivery Formulation Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transdermal Drug Delivery Formulation Historic Market Size by Region (2020-2025)
2.2.3 Transdermal Drug Delivery Formulation Forecasted Market Size by Region (2026-2031)
2.3 Transdermal Drug Delivery Formulation Market Dynamics
2.3.1 Transdermal Drug Delivery Formulation Industry Trends
2.3.2 Transdermal Drug Delivery Formulation Market Drivers
2.3.3 Transdermal Drug Delivery Formulation Market Challenges
2.3.4 Transdermal Drug Delivery Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue (2020-2025)
3.1.2 Global Transdermal Drug Delivery Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Transdermal Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transdermal Drug Delivery Formulation Revenue
3.4 Global Transdermal Drug Delivery Formulation Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Formulation Revenue in 2024
3.5 Global Key Players of Transdermal Drug Delivery Formulation Head office and Area Served
3.6 Global Key Players of Transdermal Drug Delivery Formulation, Product and Application
3.7 Global Key Players of Transdermal Drug Delivery Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Formulation Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Type (2020-2025)
4.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Type (2026-2031)
5 Transdermal Drug Delivery Formulation Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Application (2020-2025)
5.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transdermal Drug Delivery Formulation Market Size (2020-2031)
6.2 North America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
6.4 North America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Formulation Market Size (2020-2031)
7.2 Europe Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
7.4 Europe Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Formulation Market Size (2020-2031)
8.2 Asia-Pacific Transdermal Drug Delivery Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Formulation Market Size (2020-2031)
9.2 Latin America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
9.4 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Formulation Market Size (2020-2031)
10.2 Middle East & Africa Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Transdermal Drug Delivery Formulation Introduction
11.1.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Formulation Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.2.5 Mylan Recent Development
11.3 Echo Therapeutics
11.3.1 Echo Therapeutics Company Details
11.3.2 Echo Therapeutics Business Overview
11.3.3 Echo Therapeutics Transdermal Drug Delivery Formulation Introduction
11.3.4 Echo Therapeutics Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.3.5 Echo Therapeutics Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Formulation Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Transdermal Drug Delivery Formulation Introduction
11.5.4 GSK Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.5.5 GSK Recent Development
11.6 Hunan Jiudian
11.6.1 Hunan Jiudian Company Details
11.6.2 Hunan Jiudian Business Overview
11.6.3 Hunan Jiudian Transdermal Drug Delivery Formulation Introduction
11.6.4 Hunan Jiudian Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.6.5 Hunan Jiudian Recent Development
11.7 Tide Pharmaceutical
11.7.1 Tide Pharmaceutical Company Details
11.7.2 Tide Pharmaceutical Business Overview
11.7.3 Tide Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.7.4 Tide Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.7.5 Tide Pharmaceutical Recent Development
11.8 Luye Pharma
11.8.1 Luye Pharma Company Details
11.8.2 Luye Pharma Business Overview
11.8.3 Luye Pharma Transdermal Drug Delivery Formulation Introduction
11.8.4 Luye Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.8.5 Luye Pharma Recent Development
11.9 GDB
11.9.1 GDB Company Details
11.9.2 GDB Business Overview
11.9.3 GDB Transdermal Drug Delivery Formulation Introduction
11.9.4 GDB Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.9.5 GDB Recent Development
11.10 Anssure Pharma
11.10.1 Anssure Pharma Company Details
11.10.2 Anssure Pharma Business Overview
11.10.3 Anssure Pharma Transdermal Drug Delivery Formulation Introduction
11.10.4 Anssure Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.10.5 Anssure Pharma Recent Development
11.11 Novastage
11.11.1 Novastage Company Details
11.11.2 Novastage Business Overview
11.11.3 Novastage Transdermal Drug Delivery Formulation Introduction
11.11.4 Novastage Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.11.5 Novastage Recent Development
11.12 LIANSN
11.12.1 LIANSN Company Details
11.12.2 LIANSN Business Overview
11.12.3 LIANSN Transdermal Drug Delivery Formulation Introduction
11.12.4 LIANSN Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.12.5 LIANSN Recent Development
11.13 KBD
11.13.1 KBD Company Details
11.13.2 KBD Business Overview
11.13.3 KBD Transdermal Drug Delivery Formulation Introduction
11.13.4 KBD Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.13.5 KBD Recent Development
11.14 CosMED Pharmaceutical
11.14.1 CosMED Pharmaceutical Company Details
11.14.2 CosMED Pharmaceutical Business Overview
11.14.3 CosMED Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.14.4 CosMED Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.14.5 CosMED Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
Mylan
Echo Therapeutics
Novartis
GSK
Hunan Jiudian
Tide Pharmaceutical
Luye Pharma
GDB
Anssure Pharma
Novastage
LIANSN
KBD
CosMED Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂